Table 8. Relationship between Transgelin expression and clinicopathological features of Stage III CRC.
Variables | Number (n) | Transgelin expression | p-value | |
---|---|---|---|---|
Positive (n=84) | Negative (n=108) | |||
Gender | 0.461 | |||
Male | 112 | 52 | 60 | |
Female | 80 | 32 | 48 | |
Ages (years) | 0.841 | |||
>=65 | 91 | 41 | 50 | |
<65 | 101 | 43 | 58 | |
Tumor location | 0.767 | |||
ascending colon | 97 | 42 | 55 | |
transverse colon | 7 | 4 | 3 | |
descending colon | 88 | 38 | 50 | |
CEA level (mg/L) | 7.11±7.45 | 22.11±32.87 | <0.001* | |
Tumor differentiation | 0.285 | |||
Well | 21 | 7 | 14 | |
Moderate | 135 | 64 | 71 | |
Poor | 36 | 13 | 23 | |
AJCC stage | 0.027* | |||
IIIA | 7 | 5 | 2 | |
IIIB | 124 | 60 | 64 | |
IIIC | 61 | 19 | 42 |
Statistically significant (p<0.05)